Indicators of clinical response to treatment with six-mercaptopurine or asathioprine in patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 10, Issue 4, 2004, Pages 339-345

  Achkar, Jean Paul ^b   Stevens, Tyler ^b   Easley, Kirk ^a   Brzezinski, Aaron ^b   Seidner, Douglas ^b   Lashner, Bret ^b  

^a EMORY UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Azathioprine; Six mercaptopurine; Six thioguarine nucleotides

Indexed keywords

AZATHIOPRINE; DRUG METABOLITE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG FORMULATION; DRUG RESPONSE; ENTERITIS; ERYTHROCYTE COUNT; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PATIENT CODING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

6-MERCAPTOPURINE; ADULT; ANTIRHEUMATIC AGENTS; AZATHIOPRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LEUKOPENIA; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 3543150184     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200407000-00003     Document Type: Article

References (18)

1. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study. N Engl J Med. 1980;302:981-987.
2. Pearson DC, May GT, Fick GH, et al. Azathioprine and 6-mercaptopurine in Crohn disease: a meta-analysis. Ann Intern Med. 1995;122:132-142.
3. O'Donaghue DP, Dawson AW, Powell-Tuck J, et al. Double-blind withdrawal trial of azathioprine as maintenance treatment of Crohn's disease. Lancet. 1978;2:955-957.
4. Pearson DC, May GR, Fick G, et al. Azathioprine for maintenance of remission of Crohn's disease (Cochrane Review). In: The Cochrane Library, Issue 3, 1999. Oxford: Update Software.
5. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol. 1996;91:423-433.
6. Colonna T, Korelitz BI. The role of leukopenia in 6-mercaptopurine induced remission of refractory Crohn's disease. Am J Gastroenterol. 1994; 89:362-366.
7. Van Scoik KG, Johnson CA, Porter WR. The pharmacology and metabolista of thiopurine drugs 6-mercaptopurine and azathioprine. Drug Metab Rev. 1985;16:157-174.
8. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol. 1992;43:329-339.
9. Winkelstein A. The effects of azathioprine and 6 MP on immunity. J Immunopharmacology. 1979; 1:429-454.
10. Cuffari C, Theoret Y, Latour S, et al. 6-mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut. 1996;39: 401-406.
11. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705-713.
12. Cuffari C, Hunt S, Bayless T. Utilization of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease. Gut. 2001;48:642-646.
13. Dubinsky M, Hassard P, Yang HY, et al. 6-MP metabolite levels correlate with clinical response and drug toxicity in adult IBD. [abstract] Am J Gastroenterol. 1999;94:2641.
14. Dubinsky M, Yang H, Hassard PV, et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology. 2002; 122:904-915.
15. Lowry PW, Franklin CL, Weaver AL, et al. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut. 2001;49:665-70.
16. Sandborn WJ, Tremaine WJ, Wolf DC, et al. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. Gastroenterology. 1999;117:527-535.
17. Belaiche J, Desager JP, Horsmans Y, et al. Therapeutic monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scan J Gastroenterol. 2001;36:71-76.
18. Gupta P, Gokhale R, Kirschner B. 6-Mercaptopurine levels in children with inflammatory bowel disease. J Pediatr Gastroenterol Nut. 2001;33: 450-454.